Shifting Paradigms in TNBC Treatment: Emerging Alternatives to Capecitabine in the Post-Neoadjuvant Setting.

Background: Triple-negative breast cancer (TNBC) remains a clinically challenging subtype due to its aggressive nature and limited treatment options post-neoadjuvant failure. Historically, capecitabine has been the cornerstone of adjuvant therapy for TNBC patients not achieving a pathological comple...

Full description

Bibliographic Details

Published in:	Current Oncology Vol. 31; no. 7; pp. 3771 - 3783
Main Authors:	Abahssain, Halima, Souadka, Amine, Alem, Rania, Santoni, Matteo, Battelli, Nicola, Amela, Eric, Lemaire, Antoine, Rodriguez, Joseph, Errihani, Hassan
Format:	Journal Article
Published:	MDPI Jul2024
Online Access:	View this record in EBSCOhost